Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine.
Although migraine is more common in women than men and often linked to the menstrual cycle, few studies have investigated the biological basis of hormonal influences on the trigeminovascular system. In the present study we investigated the effect of physiological levels (10(-9) m) oestrogen on female rat trigeminal ganglia in vitro. Immunocytochemical analysis demonstrated the presence of oestrogen receptor-alpha in a predominantly cytoplasmic location and in neurites. Microarray analysis demonstrated that oestrogen treatment regulates several genes with potential relevance to menstrual migraine. The genes that were upregulated included synapsin-2, endothelin receptor type B, activity and neurotransmitter-induced early gene 7 (ania-7), phosphoserine aminotransferase, MHC-1b, and ERK-1. Down-regulated genes included IL-R1, bradykinin B2 receptor, N-tropomodulin, CCL20, GABA transporter protein, fetal intestinal lactase-phlorizin hydrolase, carcinoembryonic antigen-related protein, zinc finger protein 36, epsin 1 and cysteine string protein. Protein activity assays demonstrated that exposure of the cultured neurons to oestrogen leads to activation of ERK, which has been linked to inflammatory pain. Immunocytochemistry demonstrated that activated ERK was present in neurons containing peripherin, a marker of nociceptive neurons. Several of the genes in the present study may provide potential targets for understanding the association of oestrogen with migraine and other hormone-related orofacial pain.
Puri
V
V
Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Puri
S
S
Svojanovsky
S R
SR
Mathur
S
S
Macgregor
R R
RR
Klein
R M
RM
Welch
K M A
KM
Berman
N E J
NE
D000818:Animals; D002478:Cells, Cultured; D047628:Estrogen Receptor alpha / Q000235:genetics; D004967:Estrogens / Q000494:pharmacology* / Q000502:physiology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000235:genetics / Q000378:metabolism; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D066298:In Vitro Techniques; D020935:MAP Kinase Signaling System / Q000187:drug effects; D008881:Migraine Disorders / Q000235:genetics / Q000503:physiopathology*; D009475:Neurons, Afferent / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology; D020411:Oligonucleotide Array Sequence Analysis; D010766:Phosphorylation / Q000187:drug effects; D051381:Rats; D012668:Trigeminal Ganglion / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*
D047628:Estrogen Receptor alpha; D004967:Estrogens; D048049:Extracellular Signal-Regulated MAP Kinases